Pilot Study of the Human Metagenome in Metabolic Diseases - Trial NCT06363253
Access comprehensive clinical trial information for NCT06363253 through Pure Global AI's free database. This phase not specified trial is sponsored by Sengkang General Hospital and is currently Recruiting. The study focuses on Obesity,Sarcopenia,Sarcopenic Obesity,Chronic Inflammation,Metabolic Syndrome. Target enrollment is 600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
No specific intervention
Observational
other
Sponsor & Location
Sengkang General Hospital
Timeline & Enrollment
N/A
Aug 14, 2023
Dec 31, 2027
Primary Outcome
Metagenomic alterations,Metabolomic alterations
Summary
This is a cohort study to understand the role of the human metagenome, and associated
 metabolites, in health and in various diseased states, in particular obesity as well as
 sarcopenia.
 
 Recruited participants will have their fecal, salivary, urine, serum, and in certain
 instances, mucosal samples taken, for metagenomic sequencing and metabolite testing.
 
 We hope to uncover various differences and signatures in the metagenome and metabolome in
 various diseased states, with potential future therapeutic applications in personalised
 medicine.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06363253
Non-Device Trial